In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Luca Quagliata, Vice President and Global Head of Medical and Scientific Affairs at Thermo Fisher Scientific, a company
Modern medicine moves ever more to precision, personalised medicine, and precision dosing is critical in a world that recognises biological individuality – especially when it comes to paedi
As the pharmaceutical industry continues its shift towards more patient-centric models, the incorporation of social determinants of health (SDOH) data has become increasingly valuable.
Precision medicine is oft spoken about these days, as it is finally addressing the elephant in the room: one size – or, more appropriately, one dose – does not fit all.
Proscia, an AI-enabled pathology solutions software company, has announced the launch of Concentriq Embeddings and the Proscia AI Toolkit, hoping to accelerate precision medicine R&D.
In the era of precision medicine, life sciences teams can utilise real-world data (RWD) to generate actionable real-world evidence (RWE) about how to develop and deliver more targeted medic
In a new white paper from the World Without Disease initiative, a 2024 update is provided of the current endeavours and developments that have occurred since inaugural discussions last year